Skip to content
Screener

Harrow HROW Other operating expenses

Other operating expenses at other companies

Eton Pharmaceuticals, Inc. logo
Eton Pharmaceuticals, Inc.ETON
$12.32M+19.3%
Bausch + Lomb logo
Bausch + LombBLCO
-$25M-13.6%
Bausch Health Companies logo
Bausch Health CompaniesBHC
-$32M-113%
Kodiak Sciences Inc logo
Kodiak Sciences IncKOD
$59.78M+1.2%
AMP
Amphastar PharmaceuticalsAMPH
$53.74M+21.3%
Schering-Plough logo
Schering-PloughSGP

Other financials

Income statement

See full
Revenue$70.7M+10.9%
Gross profit$50.4M+6.0%
Operating income-$11.0M-196%
Net income-$17.3M-446%
EPS (diluted)-$0.46-454%

Balance sheet

See full
Cash & equivalents$83.9M+58.4%
Total debt$308.4M-32.0%
Total equity$15.2M-69.4%
Total assets$416.8M+20.8%

Cash flow

See full
Operating cash flow-$9.8M
CapEx$491.0K+196%
Free cash flow-$10.2M

Valuation

See full
Market cap$1.49B+22.8%
Enterprise value$1.71B+6.2%
P/S5.4×+0.1×

Profitability

See full
Gross margin73.3%-1.3pp
Operating margin-1%-7.3pp
Net margin-19.8%+18.0pp
FCF margin1.8%+1.3pp

Returns & leverage

See full
Return on equity-50%+17.5pp
Debt / equity20.3×+11.2×
Current ratio2.2×+1.6×

Where this comes from

Reported directly by Harrow in its filing.

Tagged under the XBRL concept us-gaap:OperatingExpenses.

The source filing: Harrow’s 10-Q, filed August 10, 2026.

Filed
Aug 10, 2026, 4:28 PM EDT
Fiscal quarter
Q2 FY2026
Calendar quarter
Q2 2026
Accession
0001628280-26-055271
Line itemFor the Three Months Ended June 30, 2026For the Three Months Ended June 30, 2025For the Six Months Ended June 30, 2026For the Six Months Ended June 30, 2025
Operating expenses:
Selling, general and administrative53,298,00033,235,00096,528,00073,748,000
Research and development8,072,0002,868,00013,967,0005,894,000
Total operating expenses61,370,00036,103,000110,495,00079,642,000
(Loss) income from operations(11,007,000)11,409,000(33,087,000)177,000
Interest expense, net(6,263,000)(6,408,000)(11,760,000)(12,956,000)
Other (expense) income, net(6,000)(6,000)
(Loss) income before income taxes(17,270,000)4,995,000(44,847,000)(12,785,000)

Item 1. Financial Statements

FAQ

What is Harrow's other operating expenses?
Harrow (HROW) reported other operating expenses of $61.37M in Q2 2026.
How has Harrow's other operating expenses changed year-over-year?
Harrow's other operating expenses increased by 70.0% year-over-year, from $36.1M to $61.37M.
What is the long-term trend for Harrow's other operating expenses?
Over 4 years (2021 to 2025), Harrow's other operating expenses has grown at a 34.8% compound annual growth rate (CAGR), from $52.65M to $173.85M.
What does other operating expenses mean?
Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.

Ask your AI about Harrow's other operating expenses.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude